Your browser doesn't support javascript.
loading
[The PRISMA 2020 statement: an updated guideline for reporting systematic reviewsDeclaración PRISMA 2020: una guía actualizada para la publicación de revisiones sistemáticas]. / A declaração PRISMA 2020: diretriz atualizada para relatar revisões sistemáticas.
Page, Matthew J; McKenzie, Joanne E; Bossuyt, Patrick M; Boutron, Isabelle; Hoffmann, Tammy C; Mulrow, Cynthia D; Shamseer, Larissa; Tetzlaff, Jennifer M; Akl, Elie A; Brennan, Sue E; Chou, Roger; Glanville, Julie; Grimshaw, Jeremy M; Hróbjartsson, Asbjørn; Lalu, Manoj M; Li, Tianjing; Loder, Elizabeth W; Mayo-Wilson, Evan; McDonald, Steve; McGuinness, Luke A; Stewart, Lesley A; Thomas, James; Tricco, Andrea C; Welch, Vivian A; Whiting, Penny; Moher, David.
Afiliação
  • Page MJ; Monash University School of Public Health and Preventive Medicine Melbourne Austrália Monash University, School of Public Health and Preventive Medicine, Melbourne, Austrália.
  • McKenzie JE; Monash University School of Public Health and Preventive Medicine Melbourne Austrália Monash University, School of Public Health and Preventive Medicine, Melbourne, Austrália.
  • Bossuyt PM; University of Amsterdam Amsterdam University Medical Centres Amsterdã Holanda University of Amsterdam, Amsterdam University Medical Centres, Amsterdã, Holanda.
  • Boutron I; Université de Paris Centre of Epidemiology and Statistics Paris França Université de Paris, Centre of Epidemiology and Statistics, Paris, França.
  • Hoffmann TC; Bond University Faculty of Health Sciences and Medicine Gold Coast Austrália Bond University, Faculty of Health Sciences and Medicine, Gold Coast, Austrália.
  • Mulrow CD; University of Texas Health Science Center at San Antonio San AntonioTexas Estados Unidos University of Texas Health Science Center at San Antonio, San Antonio, Texas, Estados Unidos.
  • Shamseer L; University of Ottawa School of Epidemiology and Public Health Ottawa Canadá University of Ottawa, School of Epidemiology and Public Health, Ottawa, Canadá.
  • Tetzlaff JM; Evidence Partners Ottawa Canadá Evidence Partners, Ottawa, Canadá.
  • Akl EA; American University of Beirut Clinical Research Institute Beirute Líbano American University of Beirut, Clinical Research Institute, Beirute, Líbano.
  • Brennan SE; Monash University School of Public Health and Preventive Medicine Melbourne Austrália Monash University, School of Public Health and Preventive Medicine, Melbourne, Austrália.
  • Chou R; Oregon Health & Science University Department of Medical Informatics and Clinical Epidemiology PortlandOregon Estados Unidos Oregon Health & Science University, Department of Medical Informatics and Clinical Epidemiology, Portland, Oregon, Estados Unidos.
  • Glanville J; University of York York Health Economics Consortium York Reino Unido University of York, York Health Economics Consortium, York, Reino Unido.
  • Grimshaw JM; Ottawa Hospital Research Institute Clinical Epidemiology Program Ottawa Canadá Ottawa Hospital Research Institute, Clinical Epidemiology Program, Ottawa, Canadá.
  • Hróbjartsson A; University of Southern Denmark Department of Clinical Research Odense Dinamarca University of Southern Denmark, Department of Clinical Research, Odense, Dinamarca.
  • Lalu MM; Ottawa Hospital Department of Anesthesiology and Pain Medicine Ottawa Canadá Ottawa Hospital, Department of Anesthesiology and Pain Medicine, Ottawa, Canadá.
  • Li T; University of Colorado Denver School of Medicine DenverClorado United States University of Colorado Denver, School of Medicine, Denver, Colorado, United States.
  • Loder EW; Harvard Medical School Brigham and Women's Hospital BostonMassachusetts Estados Unidos Harvard Medical School, Brigham and Women's Hospital, Boston, Massachusetts, Estados Unidos.
  • Mayo-Wilson E; Indiana University School of Public Health-Bloomington Department of Epidemiology and Biostatistics BloomingtonIndiana Estados Unidos Indiana University School of Public Health-Bloomington, Department of Epidemiology and Biostatistics, Bloomington, Indiana, Estados Unidos.
  • McDonald S; Monash University School of Public Health and Preventive Medicine Melbourne Austrália Monash University, School of Public Health and Preventive Medicine, Melbourne, Austrália.
  • McGuinness LA; University of Bristol Bristol Medical School Bristol Reino Unido University of Bristol, Bristol Medical School, Bristol, Reino Unido.
  • Stewart LA; University of York Centre for Reviews and Dissemination York Reino Unido University of York, Centre for Reviews and Dissemination, York, Reino Unido.
  • Thomas J; University College London Social Research Institute London Reino Unido University College London, Social Research Institute, London, Reino Unido.
  • Tricco AC; University of Toronto Institute of Health Management, Policy, and Evaluation Toronto Canadá University of Toronto, Institute of Health Management, Policy, and Evaluation, Toronto, Canadá.
  • Welch VA; Bruyère Research Institute Methods Centre OttawaOntario Canadá Bruyère Research Institute, Methods Centre, Ottawa, Ontario, Canadá.
  • Whiting P; University of Bristol Bristol Medical School Bristol Reino Unido University of Bristol, Bristol Medical School, Bristol, Reino Unido.
  • Moher D; Ottawa Hospital Research Institute centre for Journalology Ottawa Canadá Ottawa Hospital Research Institute, centre for Journalology, Ottawa, Canadá.
Rev Panam Salud Publica ; 46: e112, 2022.
Article em Pt | MEDLINE | ID: mdl-36601438
RESUMEN
La declaración PRISMA (Preferred Reporting Items for Systematic reviews and Meta-Analyses), publicada en 2009, se diseñó para ayudar a los autores de revisiones sistemáticas a documentar de manera transparente el porqué de la revisión, qué hicieron los autores y qué encontraron. Durante la última década, ha habido muchos avances en la metodología y terminología de las revisiones sistemáticas, lo que ha requerido una actualización de esta guía. La declaración PRISMA 2020 sustituye a la declaración de 2009 e incluye una nueva guía de presentación de las publicaciones que refleja los avances en los métodos para identificar, seleccionar, evaluar y sintetizar estudios. La estructura y la presentación de los ítems ha sido modificada para facilitar su implementación. En este artículo, presentamos la lista de verificación PRISMA 2020 con 27 ítems, y una lista de verificación ampliada que detalla las recomendaciones en la publicación de cada ítem, la lista de verificación del resumen estructurado PRISMA 2020 y el diagrama de flujo revisado para revisiones sistemáticas.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Prognostic_studies Idioma: Pt Revista: Rev Panam Salud Publica Assunto da revista: SAUDE PUBLICA Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Prognostic_studies Idioma: Pt Revista: Rev Panam Salud Publica Assunto da revista: SAUDE PUBLICA Ano de publicação: 2022 Tipo de documento: Article